These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 21659322
1. The standardize uptake value: light and shade of positron emission tomography. Bertolaccini L, Rizzardi G, Terzi A, Bianchi A. Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):969. PubMed ID: 21659322 [No Abstract] [Full Text] [Related]
2. Is there any maximum standardized uptake value variation among positron emission tomography scanners for mediastinal staging in non-small cell lung cancer? Iskender I, Kadioglu SZ, Kosar A, Atasalihi A, Kir A. Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):965-9. PubMed ID: 21441257 [Abstract] [Full Text] [Related]
3. Sentinel node and positron emission tomography mapping in lung cancer. Nwogu C. Semin Thorac Cardiovasc Surg; 2009 Jun; 21(4):323-6. PubMed ID: 20226345 [Abstract] [Full Text] [Related]
4. Pattern and predictors of false positive lymph node involvement on positron emission tomography in patients with non-small cell lung cancer. Tamura M, Oda M, Matsumoto I, Waseda R, Watanabe G. Thorac Cardiovasc Surg; 2012 Mar; 60(2):105-10. PubMed ID: 21789758 [Abstract] [Full Text] [Related]
7. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma? Sivrikoz CM, Ak I, Simsek FS, Döner E, Dündar E. Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019 [Abstract] [Full Text] [Related]
8. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer. Giaccone G. J Natl Cancer Inst; 2007 Dec 05; 99(23):1741-3. PubMed ID: 18042929 [No Abstract] [Full Text] [Related]
9. The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer. Maeda R, Isowa N, Onuma H, Miura H, Harada T, Touge H, Tokuyasu H, Kawasaki Y. Interact Cardiovasc Thorac Surg; 2009 Jul 05; 9(1):79-82. PubMed ID: 19366724 [Abstract] [Full Text] [Related]
13. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer. Muto J, Hida Y, Kaga K, Ohtaka K, Okamoto S, Tamaki N, Nakada-Kubota R, Hirano S, Matsui Y. Anticancer Res; 2014 Feb 05; 34(2):805-10. PubMed ID: 24511016 [Abstract] [Full Text] [Related]
14. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, Ojha B. Ann Thorac Surg; 2005 Jan 05; 79(1):263-8. PubMed ID: 15620955 [Abstract] [Full Text] [Related]
18. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, Kirsch CM. J Nucl Med; 2007 Nov 05; 48(11):1761-6. PubMed ID: 17942814 [Abstract] [Full Text] [Related]
20. Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer. Nishiyama Y, Yamamoto Y, Kimura N, Ishikawa S, Sasakawa Y, Ohkawa M. Ann Nucl Med; 2008 May 05; 22(4):245-50. PubMed ID: 18535874 [Abstract] [Full Text] [Related] Page: [Next] [New Search]